Investigating how IGFBP3 affects heart regeneration in newborns
Role of IGFBP3 in Neonatal Heart Regeneration
This study is looking at how a specific protein helps baby mice heal their hearts, with the goal of finding new ways to help people with heart problems feel better.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11047687 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of IGFBP3 in the regeneration of heart tissue in neonatal mice. The team, led by Dr. Shah Ali at Columbia University, aims to uncover the molecular mechanisms that allow for heart regeneration in young animals, with the hope of translating these findings into potential therapies for heart diseases in humans. By studying how the heart heals itself after injury, the researchers hope to develop new treatments that could improve heart function in patients. The methodology involves advanced laboratory techniques and collaboration with experts in cardiac biology.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with heart diseases, particularly those who are younger or have experienced heart injuries.
Not a fit: Patients with chronic heart conditions that do not involve regenerative potential or those over the age of 21 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that enhance heart regeneration in patients with heart diseases.
How similar studies have performed: Other research has shown promising results in cardiac regeneration, particularly in neonatal models, suggesting that this approach has potential for success.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Ali, Shah Rukh — Columbia University Health Sciences
- Study coordinator: Ali, Shah Rukh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.